Pharma Business：Product Development

  1. Home
  2. Pharma Business
  3. Product Development
New drug development Regeneration technology

New drug development

Product
Indication
Pre-Clinical
Phase I
Phase II
Phase III

CAR001

Malignant Tumors

0%

Phase I recruiting

ADCV01

Glioblastoma Multiforme ,GBM

0%

Phase II recruiting

UMSC01

Acute Myocardial Infarction

0%

Phase IIa recruiting

UMSC01

Acute Ischemic

0%

Phase I completed

UMSC01

COVID-19

0%

Phase I recruiting

UMSC01

Multiple sclerosis

0%

Phase I completed；Phase IIa recruiting

EXO001

Malignant Tumors

0%

Preclinical development

INSP003

Malignant Tumors

0%

Preclinical development